Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-002722
Filing Date
2022-01-10
Accepted
2022-01-10 16:07:48
Documents
1
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm221863-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm221863-2_4seq1.xml 4 14009
  Complete submission text file 0001104659-22-002722.txt   15434
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W. GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address
Dierks Jeffrey (Reporting) CIK: 0001821102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 22521342